Cite
HARVARD Citation
Tsuda, M. et al. (2020). Overnight fasting before lapatinib administration to breast cancer patients leads to reduced toxicity compared with nighttime dosing: a retrospective cohort study from a randomized clinical trial. Cancer medicine. pp. 9246-9255. [Online].